
J&J, Legend Pump $150M Into Manufacturing in Bid to Double Carvykti Production
Legend Biotech is building a new $150 million manufacturing plant, with its partner Johnson & Johnson, with the goal of doubling the production of its CAR T therapy Carvykti this year, Legend CEO Ying Huang revealed in its fourth-quarter earnings call …